Challenges in the Use of Targeted Therapies in Non–Small Cell Lung Cancer
Joel Rivera-Concepcion, Dipesh Uprety, Alex A. Adjei
Cancer Res Treat. 2022;54(2):315-329. Published online 2022 Feb 18 DOI: https://doi.org/10.4143/crt.2022.078
|
Citations to this article as recorded by
A local perspective on internal, external, and reflexive biomarker testing processes for lung cancer in an academic medical center
Andrea M. Russell, Allison P. Pack, Stacy C. Bailey, Christine B. Weldon, Marie S. Dreyer, Sheetal M. Kircher, Michael S. Wolf
Cancer.2024;[Epub] CrossRef Advances in BRAF-targeted therapies for non-small cell lung cancer: the promise of encorafenib and binimetinib
Areeba Fareed, Nabiha Amir, Humna Ajaz, Afra Sohail, Rayyan Vaid, Solay Farhat
International Journal of Surgery.2024; 110(4): 1891. CrossRef Prognostic score and sex-specific nomograms to predict survival in resectable lung cancer: a French nationwide study from the Epithor cohort database
Marco Alifano, Elisa Daffré, Laurent Brouchet, Pierre Emmanuel Falcoz, Françoise Le Pimpec Barthes, Pierre Benoit Pages, Pascal Alexandre Thomas, Marcel Dahan, Raphael Porcher
The Lancet Regional Health - Europe.2023; 26: 100566. CrossRef Proteolysis targeting chimeras in non-small cell lung cancer
Garo Hagopian, Christopher Grant, Misako Nagasaka
Cancer Treatment Reviews.2023; 117: 102561. CrossRef Nanotechnology prospects in brain therapeutics concerning gene-targeting and nose-to-brain administration
Dong-Dong Wu, Yasmine Ahmed Salah, Ebenezeri Erasto Ngowi, Yan-Xia Zhang, Saadullah Khattak, Nazeer Hussain Khan, Yan Wang, Tao Li, Zi-Hua Guo, Yan-Mei Wang, Xin-Ying Ji
iScience.2023; 26(8): 107321. CrossRef Smart Sensors and Microtechnologies in the Precision Medicine Approach against Lung Cancer
Giulia Maria Stella, Sara Lettieri, Davide Piloni, Ilaria Ferrarotti, Fabio Perrotta, Angelo Guido Corsico, Chandra Bortolotto
Pharmaceuticals.2023; 16(7): 1042. CrossRef Recent advances in non-small cell lung cancer targeted therapy; an update review
Mahmood Araghi, Reza Mannani, Ali Heidarnejad maleki, Adel Hamidi, Samaneh Rostami, Salar Hozhabri Safa, Fatemeh Faramarzi, Sahar Khorasani, Mina Alimohammadi, Safa Tahmasebi, Reza Akhavan-Sigari
Cancer Cell International.2023;[Epub] CrossRef AXL transcriptionally up-regulates TMEM14A expression to mediate cell proliferation in non-small-cell lung cancer cells
Te-Hsuan Jang, Sheng-Chieh Lin, Ya-Yu Yang, Shu-Hui Wu, Tsu-Hsiang Kuo, Shuang-En Chuang
Biochemical and Biophysical Research Communications.2023; 682: 365. CrossRef Applications of nanofibers drug delivery system in cancer therapy
Nafiu Aminu, Salim Ilyasu, Mohammed Al-Kassim Hassan, Fatima Shuaibu Kurfi, Abubakar Ibrahim Jatau, Siok-Yee Chan, Deghinmotei Alfred-Ugbenbo
Journal of Drug Delivery Science and Technology.2023; 90: 105128. CrossRef Exploring the Anticancer Potential of Origanum majorana Essential Oil Monoterpenes Alone and in Combination against Non-Small Cell Lung Cancer
Kholoud Arafat, Aya Mudhafar Al-Azawi, Shahrazad Sulaiman, Samir Attoub
Nutrients.2023; 15(23): 5010. CrossRef Novel Biomarkers in Lung Cancer and Chronic Lung Diseases: From the Systematic Perspective of Yin–Yang Balance
Mi-Kyung Jeong, Jaemoo Chun, In-Jae Oh
Journal of Clinical Medicine.2022; 11(15): 4275. CrossRef Application of Perinatal Derivatives on Oncological Preclinical Models: A Review of Animal Studies
Ricardo Teixo, Ana Salomé Pires, Eurico Pereira, Beatriz Serambeque, Inês Alexandra Marques, Mafalda Laranjo, Slavko Mojsilović, Roberto Gramignoli, Peter Ponsaerts, Andreina Schoeberlein, Maria Filomena Botelho
International Journal of Molecular Sciences.2022; 23(15): 8570. CrossRef Survival benefit of thermal ablation therapy for patients with stage II-III non-small cell lung cancer: A propensity-matched analysis
Wei-Yu Yang, Yu He, Qikang Hu, Muyun Peng, Zhe Zhang, Shouzhi Xie, Fenglei Yu
Frontiers in Oncology.2022;[Epub] CrossRef Molecular targeted therapy for anticancer treatment
Hye-Young Min, Ho-Young Lee
Experimental & Molecular Medicine.2022; 54(10): 1670. CrossRef Transcriptomic FHITlow/pHER2high signature as a predictive factor of outcome and immunotherapy response in non-small cell lung cancer
Audrey Brisebarre, Julien Ancel, Théophile Ponchel, Emma Loeffler, Adeline Germain, Véronique Dalstein, Valérian Dormoy, Anne Durlach, Gonzague Delepine, Gaëtan Deslée, Myriam Polette, Béatrice Nawrocki-Raby
Frontiers in Immunology.2022;[Epub] CrossRef CIGB-300 Anticancer Peptide Differentially Interacts with CK2 Subunits and Regulates Specific Signaling Mediators in a Highly Sensitive Large Cell Lung Carcinoma Cell Model
George V. Pérez, Mauro Rosales, Ailyn C. Ramón, Arielis Rodríguez-Ulloa, Vladimir Besada, Luis J. González, Daylen Aguilar, Dania Vázquez-Blomquist, Viviana Falcón, Evelin Caballero, Paulo C. Carvalho, Rodrigo Soares Caldeira, Ke Yang, Yasser Perera, Silv
Biomedicines.2022; 11(1): 43. CrossRef
|